Literature DB >> 24837548

Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies.

Yasuhiro Nakamura1, Takashi Maekawa1, Saulo J A Felizola1, Fumitoshi Satoh2, Xin Qi3, Carolina Velarde-Miranda3, Maria W Plonczynski3, Kazue Ise1, Kumi Kikuchi2, William E Rainey4, Elise P Gomez-Sanchez5, Celso E Gomez-Sanchez6, Hironobu Sasano7.   

Abstract

CYP11B1 and CYP11B2 play pivotal roles in adrenocorticosteroids synthesis. We performed semi-quantitative immunohistochemical analysis of these proteins in adrenals from patients with primary aldosteronism using novel monoclonal antibodies. Clusters of cortical cells positive for CYP11B2 were detected in the zona glomerulosa (ZG) of normal adrenal gland (NA), idiopathic hyperaldosteronism (IHA) and the adjacent adrenal of aldosterone-producing adenoma (APA). In APA, heterogenous immunolocalization of CYP11B2 and diffuse immunoreactivity of CYP11B1 were detected in tumor cells, respectively. The relative immunoreactivity of CYP11B2 in the ZG of adjacent adrenal of APA was significantly lower than that of NA, IHA and APA tumor cells, suggestive of suppressed aldosterone biosynthesis in these cells. These findings did indicate the regulatory mechanisms of aldosterone biosynthesis were different between normal/hyperplastic and neoplastic aldosterone-producing cells in human adrenals. CYP11B2 immunoreactivity in the ZG could also serve as a potential immunohistochemical marker differentiating morphologically hyperplastic ZG of IHA and APA adjacent adrenal.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  APA; Adrenal cortex; CYP11B1; CYP11B2; IHA; Monoclonal antibody

Mesh:

Substances:

Year:  2014        PMID: 24837548      PMCID: PMC5471353          DOI: 10.1016/j.mce.2014.05.002

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  26 in total

1.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Authors:  Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad
Journal:  J Am Coll Cardiol       Date:  2005-04-19       Impact factor: 24.094

Review 2.  Localization of steroidogenic enzymes in adrenal cortex and its disorders.

Authors:  H Sasano
Journal:  Endocr J       Date:  1994-10       Impact factor: 2.349

Review 3.  Histopathology of the human adrenal cortex.

Authors:  A M Neville; M J O'Hare
Journal:  Clin Endocrinol Metab       Date:  1985-11

4.  Aldosterone synthase cytochrome P-450 expressed in the adrenals of patients with primary aldosteronism.

Authors:  T Ogishima; H Shibata; H Shimada; F Mitani; H Suzuki; T Saruta; Y Ishimura
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

5.  Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas.

Authors:  F Fallo; V Pezzi; L Barzon; P Mulatero; F Veglio; N Sonino; J M Mathis
Journal:  Eur J Endocrinol       Date:  2002-12       Impact factor: 6.664

6.  Expression profiles for steroidogenic enzymes in adrenocortical disease.

Authors:  Mary H Bassett; Bobbie Mayhew; Khurram Rehman; Perrin C White; Franco Mantero; Giorgio Arnaldi; Paul M Stewart; Iwona Bujalska; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

7.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

8.  Characterization of steroidogenic enzyme expression in aldosterone-producing adenoma: a comparison with various human adrenal tumors.

Authors:  Ikki Sakuma; Sachiko Suematsu; Yoko Matsuzawa; Jun Saito; Masao Omura; Takashi Maekawa; Yasuhiro Nakamura; Hironobu Sasano; Tetsuo Nishikawa
Journal:  Endocr J       Date:  2012-12-18       Impact factor: 2.349

9.  The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex.

Authors:  K M Curnow; M T Tusie-Luna; L Pascoe; R Natarajan; J L Gu; J L Nadler; P C White
Journal:  Mol Endocrinol       Date:  1991-10

10.  Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway.

Authors:  Saulo J A Felizola; Yasuhiro Nakamura; Fumitoshi Satoh; Ryo Morimoto; Kumi Kikuchi; Tomohiro Nakamura; Atsushi Hozawa; Lin Wang; Yoshiaki Onodera; Kazue Ise; Keely M McNamara; Sanae Midorikawa; Shinichi Suzuki; Hironobu Sasano
Journal:  Mol Cell Endocrinol       Date:  2013-09-27       Impact factor: 4.102

View more
  38 in total

1.  Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study.

Authors:  Toyoyoshi Uchida; Koshiro Nishimoto; Yuki Fukumura; Miki Asahina; Hiromasa Goto; Yui Kawano; Fumitaka Shimizu; Akira Tsujimura; Tsugio Seki; Kuniaki Mukai; Yasuaki Kabe; Makoto Suematsu; Celso E Gomez-Sanchez; Takashi Yao; Shigeo Horie; Hirotaka Watada
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

2.  Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.

Authors:  Francesco Fallo; Isabella Castellano; Celso E Gomez-Sanchez; Yara Rhayem; Catia Pilon; Valentina Vicennati; Donatella Santini; Valeria Maffeis; Ambrogio Fassina; Paolo Mulatero; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

Review 3.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 4.  Development of adrenal cortex zonation.

Authors:  Yewei Xing; Antonio M Lerario; William Rainey; Gary D Hammer
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

5.  A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.

Authors:  Masanori Murakami; Takanobu Yoshimoto; Isao Minami; Ryotaro Bouchi; Kyoichiro Tsuchiya; Koshi Hashimoto; Hajime Izumiyama; Yasuhisa Fujii; Takashi Endo; Takumi Akashi; Koshiro Nishimoto; Kuniaki Mukai; Kazunori Kihara; Yoshihiro Ogawa
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

6.  A Novel Phenotype of Familial Hyperaldosteronism Type III: Concurrence of Aldosteronism and Cushing's Syndrome.

Authors:  Anli Tong; Guanghua Liu; Fen Wang; Jun Jiang; Zhaoli Yan; Dianxi Zhang; Yinsheng Zhang; Jun Cai
Journal:  J Clin Endocrinol Metab       Date:  2016-07-12       Impact factor: 5.958

Review 7.  Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Koshiro Nishimoto
Journal:  Horm Metab Res       Date:  2020-04-14       Impact factor: 2.936

Review 8.  Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.

Authors:  Ozgur Mete; Sylvia L Asa; Thomas J Giordano; Mauro Papotti; Hironobu Sasano; Marco Volante
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

9.  Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.

Authors:  Kei Omata; Fumitoshi Satoh; Ryo Morimoto; Sadayoshi Ito; Yuto Yamazaki; Yasuhiro Nakamura; Sharath K Anand; Zeng Guo; Michael Stowasser; Hironobu Sasano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

Review 10.  DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?

Authors:  Jacques W M Lenders; Tracy Ann Williams; Martin Reincke; Celso E Gomez-Sanchez
Journal:  Eur J Endocrinol       Date:  2017-09-13       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.